相关实验视频
Updated: May 10, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.4K
心肌炎和炎症性心肌病在扩张性心力衰竭中
1Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Viruses
|April 26, 2025
概括
炎症性心肌病包括由各种原因引起的心肌炎症,通常是病毒性. 了解其进展和结果是更好的诊断和治疗病毒性心肌炎的关键.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性心肌病症的特征是心肌炎症,导致心脏功能受损.
- 病因有多种,包括病毒,细菌,真菌感染,毒素,药物和自身免疫性疾病.
- 结果各不相同,一些患者经历了解决方案,而另一些患者患有扩张性心肌病.
研究的目的:
- 审查和评估当前关于病毒诱导和病毒相关心肌炎和炎症性心肌病的发病,诊断和治疗的证据.
- 识别知识差距并评估现有的实验模型.
- 提出未来的研究方向,包括宿主基因组学和环境因素的作用.
主要方法:
- 关于病毒性心肌炎和炎症性心肌病的综合文献综述.
- 分析当前对病原机制和宿主-病原体相互作用的理解.
- 对诊断和治疗策略的评估.
主要成果:
- 病毒感染是主要原因,但不同病毒 (例如CVB3,腺病毒,SARS-CoV-2) 和宿主免疫反应的具体作用尚不清楚.
- 影响疾病进展和解决的因素,包括宿主基因组学和环境影响,需要进一步调查.
- 感染SARS-CoV-2的心血管影响是正在进行的研究的一个重要领域.
结论:
- 需要进一步的研究,以阐明导致炎性心肌病的有利或不利结果的确切机制.
- 识别关键宿主免疫特征和了解病毒作用对于向疗法至关重要.
- 未来的研究应侧重于差异性基因表达,代谢重塑和改善病毒引起的心脏病的实验模型.
相关概念视频
01:23Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
01:26Heart Failure Drugs: Inotropic Agents
405
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
405
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:29Pathophysiology of Cardiac Performance
486
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
486
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305